<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="17698">Chloramphenicol</z:chebi> is a broad-spectrum antibiotic used for the treatment of many <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious diseases</z:e> and has become one of the major seafood contaminants </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">Hematologic disorders</z:e> such as <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and <z:hpo ids='HP_0001909'>leukemia</z:hpo> induced by <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi> are a major concern </plain></SENT>
<SENT sid="2" pm="."><plain>However, the mechanism underlying <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi>-induced <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> is not known </plain></SENT>
<SENT sid="3" pm="."><plain>By investigating the effects of <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi> on the activation of mouse T cells stimulated with anti-CD3 antibody or staphylococcal enterotoxin B, we found that <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi> induces the differentiation of activated T cells into lymphoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo>-like cells, characterized by large cell size, multiploid nuclei, and expression of CD7, a maker for immature T cells and T-cell lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, thus phenotypically indicating differentiation toward <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>High expression of cyclin B1, but not p53, c-myc, and CDC25A, was detected in <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi>-treated activated T cells, which may relate to <z:mp ids='MP_0005076'>abnormal cell differentiation</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="17698">Chloramphenicol</z:chebi> inhibited the activation-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> of mouse and human T-cell receptor-activated T cells by down-regulating the expression of Fas ligand </plain></SENT>
<SENT sid="6" pm="."><plain>Our findings show that <z:mp ids='MP_0005076'>abnormal cell differentiation</z:mp> and inhibition of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> may contribute to the development of <z:hpo ids='HP_0001909'>leukemia</z:hpo> associated with clinical applications of <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi> </plain></SENT>
</text></document>